187 related articles for article (PubMed ID: 24329564)
1. Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications.
Patel VB; Parajuli N; Oudit GY
Clin Sci (Lond); 2014 Apr; 126(7):471-82. PubMed ID: 24329564
[TBL] [Abstract][Full Text] [Related]
2. Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes.
Tikellis C; Pickering R; Tsorotes D; Du XJ; Kiriazis H; Nguyen-Huu TP; Head GA; Cooper ME; Thomas MC
Clin Sci (Lond); 2012 Oct; 123(8):519-29. PubMed ID: 22616805
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors.
Huang ML; Li X; Meng Y; Xiao B; Ma Q; Ying SS; Wu PS; Zhang ZS
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):e1-6. PubMed ID: 19793108
[TBL] [Abstract][Full Text] [Related]
4. Emerging markers in cardiovascular disease: where does angiotensin-converting enzyme 2 fit in?
Patel SK; Velkoska E; Burrell LM
Clin Exp Pharmacol Physiol; 2013 Aug; 40(8):551-9. PubMed ID: 23432153
[TBL] [Abstract][Full Text] [Related]
5. Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis.
Patel VB; Bodiga S; Basu R; Das SK; Wang W; Wang Z; Lo J; Grant MB; Zhong J; Kassiri Z; Oudit GY
Circ Res; 2012 May; 110(10):1322-35. PubMed ID: 22474255
[TBL] [Abstract][Full Text] [Related]
6. ACE2 and diabetic complications.
Dean RG; Burrell LM
Curr Pharm Des; 2007; 13(26):2730-5. PubMed ID: 17897017
[TBL] [Abstract][Full Text] [Related]
7. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
[TBL] [Abstract][Full Text] [Related]
8. Identification of angiotensin converting enzyme 2 in the rodent retina.
Tikellis C; Johnston CI; Forbes JM; Burns WC; Thomas MC; Lew RA; Yarski M; Smith AI; Cooper ME
Curr Eye Res; 2004 Dec; 29(6):419-27. PubMed ID: 15764086
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling.
McKinney CA; Fattah C; Loughrey CM; Milligan G; Nicklin SA
Clin Sci (Lond); 2014 Jun; 126(12):815-27. PubMed ID: 24593683
[TBL] [Abstract][Full Text] [Related]
10. Regulation of angiotensin II receptors beyond the classical pathway.
Horiuchi M; Iwanami J; Mogi M
Clin Sci (Lond); 2012 Aug; 123(4):193-203. PubMed ID: 22548405
[TBL] [Abstract][Full Text] [Related]
11. Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats.
Leehey DJ; Singh AK; Bast JP; Sethupathi P; Singh R
Transl Res; 2008 Apr; 151(4):208-16. PubMed ID: 18355768
[TBL] [Abstract][Full Text] [Related]
12. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition.
Inaba S; Iwai M; Furuno M; Kanno H; Senba I; Okayama H; Mogi M; Higaki J; Horiuchi M
J Hypertens; 2011 Nov; 29(11):2236-45. PubMed ID: 21946695
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin converting enzyme 2 and the kidney.
Ortiz-Melo DI; Gurley SB
Curr Opin Nephrol Hypertens; 2016 Jan; 25(1):59-66. PubMed ID: 26575394
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity.
Ottlecz A; Bensaoula T; Eichberg J; Peterson RG
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2157-64. PubMed ID: 8843902
[TBL] [Abstract][Full Text] [Related]
15. New pathways of the renin-angiotensin system: the role of ACE2 in cardiovascular pathophysiology and therapy.
Castro-Chaves P; Cerqueira R; Pintalhao M; Leite-Moreira AF
Expert Opin Ther Targets; 2010 May; 14(5):485-96. PubMed ID: 20392165
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular protection by angiotensin-converting enzyme 2: a new paradigm.
Ferreira AJ; Hernández Prada JA; Ostrov DA; Raizada MK
Future Cardiol; 2008 Mar; 4(2):175-82. PubMed ID: 19804294
[TBL] [Abstract][Full Text] [Related]
17. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
18. ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy.
Cole-Jeffrey CT; Liu M; Katovich MJ; Raizada MK; Shenoy V
J Cardiovasc Pharmacol; 2015 Dec; 66(6):540-50. PubMed ID: 26322922
[TBL] [Abstract][Full Text] [Related]
19. Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice.
Shiota A; Yamamoto K; Ohishi M; Tatara Y; Ohnishi M; Maekawa Y; Iwamoto Y; Takeda M; Rakugi H
Hypertens Res; 2010 Apr; 33(4):298-307. PubMed ID: 20186149
[TBL] [Abstract][Full Text] [Related]
20. Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options.
Grace JA; Herath CB; Mak KY; Burrell LM; Angus PW
Clin Sci (Lond); 2012 Aug; 123(4):225-39. PubMed ID: 22548407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
